highly significantP < 0.05
In contrast, the group OPN5 demonstrated a highly significant increase in the anti-OPN5 antibody titer after 15 d of the initial immunization ( P < 0.05), which subsequently remained high throughout the trial period and was significantly higher than the group CL and group CS ( P < 0.05).